Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national
national blog main
national top stories
new york top stories
5
×
novartis
5
×
roche
5
×
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
biogen
cancer
clinical trials
drug prices
gene therapy
immunotherapy
medicare
president trump
spark therapeutics
What
drug
bio
patients
roundup
latest
new
plan
acquisitions
advantages
albert
alzheimer’s
american
annual
approved
ash
atrophy
bar
biggest
blood
borne
bourla
brings
cancers
ceo
companies
company
conference
crispr
daily
diego
different
evrysdi
expect
fail
fda
friday
future
gamble
gathering
gene
Language
unset
unknown
Current search:
roche
×
novartis
×
" new york top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
